deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03008993

A Stepped Wedge Cluster Randomized Controlled Trial to Assess a Strategy Aiming to Optimize Psychosocial Outcomes in Patients With Cancer (HuCare2)

Trial Clinico Controllato e Randomizzato, Con Disegno a Cluster Stepped-wedge, Per Valutare Una Strategia Volta ad Ottimizzare Gli Outcomes Psicosociali in Pazienti Affetti da Cancro

Sponsor: Azienda Ospedaliero-Universitaria di Parma

Conditions Cancer
Interventions HQIS implementation
Updated 12 times since 2017 Last updated: Feb 25, 2019 Started: Oct 17, 2016 Primary completion: Nov 6, 2018 Completion: Nov 6, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03008993, this NA trial focuses on Cancer and remains completed. Sponsored by Azienda Ospedaliero-Universitaria di Parma, it has been updated 12 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Mar 2019 · 6 months · monthly snapshotActive Not Recruiting~Mar 2019 – ~Jul 2019 · 4 months · monthly snapshotCompleted~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotCompleted~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshotCompleted~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

12 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Apr 2025 — Sep 2025 [monthly]

    Completed NA

  3. Mar 2025 — Apr 2025 [monthly]

    Completed NA

  4. Sep 2024 — Mar 2025 [monthly]

    Completed NA

  5. Jul 2024 — Sep 2024 [monthly]

    Completed NA

Show 7 earlier versions
  1. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  2. Jul 2019 — Jan 2021 [monthly]

    Completed NA

  3. Mar 2019 — Jul 2019 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  4. Sep 2018 — Mar 2019 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  5. Jun 2018 — Sep 2018 [monthly]

    Recruiting NA

  6. Feb 2017 — Jun 2018 [monthly]

    Recruiting NA

    Status: Active Not RecruitingRecruiting

  7. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting NA

    First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Azienda Ospedaliero-Universitaria di Parma
  • Azienda USL Reggio Emilia - IRCCS
  • Centro di Riferimento Oncologico - Aviano
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
  • IRCCS Sacro Cuore Don Calabria di Negrar
  • Istituti Ospitalieri di Cremona
  • Istituto Di Ricerche Farmacologiche Mario Negri
Data source: Istituti Ospitalieri di Cremona

For direct contact, visit the study record on ClinicalTrials.gov .